IFC Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

IFC Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-23,803	Closed	-$2.02M	–	446
2017 Q4	$2.02M	Sell	23,803 -1,919	-7%	-$161K	0.14%	99
2017 Q3	$2.23M	Buy	25,722 +20,449	+388%	+$1.64M	0.16%	106
2017 Q2	$407K	Buy	5,273 +530	+11%	+$37.6K	0.03%	331
2017 Q1	$326K	Buy	4,743 +560	+13%	+$37.6K	0.03%	332
2016 Q4	$247K	Sell	4,183 -16	-0.4%	-$988	0.02%	346
2016 Q3	$278K	Buy	+4,199	New	+$260K	0.03%	313

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

IFC Holdings's XBI Position: Q1 2018 in Review

IFC Holdings sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2018, closing a stake of 23,803 shares — an estimated $2.02M sold.

IFC Holdings first reported a position in XBI in Q3 2016 and held it in 6 quarters. The position peaked at $2.23M in Q3 2017. 414 funds tracked by Wall St. Rank hold XBI as of Q1 2018.

IFC Holdings reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2018 after selling out during the quarter.
IFC Holdings sold 23,803 State Street SPDR S&P Biotech ETF shares in Q1 2018, an estimated $2.02M.
IFC Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and held it in 6 quarters.
IFC Holdings's State Street SPDR S&P Biotech ETF position peaked at $2.23M in Q3 2017.
414 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2018.

Based on IFC Holdings's 13F filing for Q1 2018.